Novogene (UK) Company Limited is registered at the Bio-Innovation Centre on Cambridge Science Park, a site known for high-tech bioscience enterprises. The company was incorporated on 12 December 2014 and its primary SIC code identifies it as a research and experimental development firm in biotechnology. The name points to an affiliation with the Novogene group, an international genomics services provider headquartered in China. From that affiliation and the usual pattern of such subsidiaries, its role is most likely to deliver or support genomics services — DNA sequencing, gene expression analysis, genotyping, and related bioinformatics — for academic institutions and pharmaceutical or biotech clients across Europe. This is an inference from the company name and industry norms rather than a listed fact. The Companies House record shows an active limited company with no publicly disclosed workforce size, but a subsidiary of this nature would typically operate with a compact specialist team. The company holds a Worker (A-rated) sponsor licence under the Skilled Worker route, which means it has met Home Office requirements to hire overseas staff and appears willing to sponsor visas. That status, combined with its research orientation, suggests it is a plausible target for applicants with laboratory or computational biology skills, especially those seeking sponsorship. Its location in Cambridge, a major European biotech cluster, reinforces the likelihood of collaboration with nearby research institutions. Overall, the company is a small but professionally run biotech R&D operation with visible international links and an active visa sponsorship capability.

Novogene (UK) Company Limited is registered at the Bio-Innovation Centre on Cambridge Science Park, a site known for high-tech bioscience enterprises. The company was incorporated on 12 December 2014 and its primary SIC code identifies it as a research and experimental development firm in biotechnology. The name points to an affiliation with the Novogene group, an international genomics services provider headquartered in China. From that affiliation and the usual pattern of such subsidiaries, its role is most likely to deliver or support genomics services — DNA sequencing, gene expression analysis, genotyping, and related bioinformatics — for academic institutions and pharmaceutical or biotech clients across Europe. This is an inference from the company name and industry norms rather than a listed fact. The Companies House record shows an active limited company with no publicly disclosed workforce size, but a subsidiary of this nature would typically operate with a compact specialist team. The company holds a Worker (A-rated) sponsor licence under the Skilled Worker route, which means it has met Home Office requirements to hire overseas staff and appears willing to sponsor visas. That status, combined with its research orientation, suggests it is a plausible target for applicants with laboratory or computational biology skills, especially those seeking sponsorship. Its location in Cambridge, a major European biotech cluster, reinforces the likelihood of collaboration with nearby research institutions. Overall, the company is a small but professionally run biotech R&D operation with visible international links and an active visa sponsorship capability.